MedCity News » Genomics

At Northshore–Edward Elmhurst Health, all patients are offered genetic testing as part of their primary care visit. This helps clinicians create more personalized care plans and facilitates...

https://medcitynews.com/2023/11/genomics-genetics-primary-care/

By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality car...

https://medcitynews.com/2023/06/accelerating-the-move-to-precision-oncology/

Optimizing drug routines allows prescribers to make more informed decisions that reduce risk and improve quality of care. The result is better outcomes for both patients and organizations. ...

https://medcitynews.com/2023/02/improving-value-based-care-with-optimized-drug-therapy/

Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale g...

https://medcitynews.com/2023/01/nest-genomics-raises-8-5m-to-increase-access-to-patients-genetic-information/

Without the help of genomics specialists, it is hard for health plans to manage genomic benefits efficiently and effectively. Now is the time for health plans to evaluate their genomic benefi...

https://medcitynews.com/2022/12/overcome-genomics-benefits-management-vulnerabilities-with-vetted-expertise/

In a recent interview, Jennifer Cubino, COO of BC Platforms, discussed regulatory differences between the U.S., the European Union and other countries amid ongoing efforts to encourage patien...

https://medcitynews.com/2022/08/putting-patients-at-the-center-of-rwd-collection-processes/

Illumina Accelerator has invested in 68 companies so far, all of them startups developing genomics technologies. Seven startups comprise the latest cohort selected by the startup engine. Th...

https://medcitynews.com/2022/03/illumina-accelerator-unveils-7-genomics-startups-selected-for-latest-funding-cycle/

All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significan...

https://medcitynews.com/2022/03/precision-medicine-a-new-dimension-to-improve-care-outcomes/

Learn how healthcare organizations are working with Microsoft to enhance patient engagement, accelerate healthcare innovation, support collaboration, improve clinical and operational insight...

https://medcitynews.com/2021/11/reimagine-healthcare-transform-healthcare-in-the-cloud/

Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics analysis solutions, Bionano said combining its te...

https://medcitynews.com/2021/10/bionano-frames-90m-biodiscovery-buy-as-way-to-expand-genomics-analysis/

Combining the two companies would allow patients to access genetic testing and their health records in one place, and make it easier for Invitae to collect and organize health records.  Th...

https://medcitynews.com/2021/09/invitae-to-buy-health-records-startup-ciitizen-for-325m/

With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools th...

https://medcitynews.com/2021/07/sema4-goes-public-via-spac-merger/

The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video reco...

https://medcitynews.com/2021/07/check-out-video-highlights-of-invest-precision-medicine-conference-from-pediatrics-to-funding-trends/

Read new developments from Serimmune, Allelica, ForSight Robotics, Owlet Baby Care Inc., and Ascension Ventures. The post StartUPDATES: New developments for healthcare startups appeared fi...

https://medcitynews.com/2021/03/startupdates-new-developments-for-healthcare-startups-19/

Read about news from Seven Bridges, Outcomes4Me, Carrum Health and more. The post StartUPDATES: New developments for healthcare startups appeared first on MedCity News .

https://medcitynews.com/2021/02/startupdates-new-developments-for-healthcare-startups-18/

Check out news from healthcare startups including Carrum Health, Seven Bridges Genomics, Outcomes4Me and more. The post StartUPDATES: New developments from healthcare startups appeared fir...

https://medcitynews.com/2021/01/startupdates-new-developments-from-healthcare-startups-21/

Check out news from healthcare startups including Truvian Sciences and Seven Bridges Genomics. The post StartUPDATES: New developments for healthcare startups appeared first on MedCity New...

https://medcitynews.com/2020/11/startupdates-new-developments-for-healthcare-startups-15/

The Chicago-based startup company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners. The post CancerIQ raises $4.8M S...

https://medcitynews.com/2020/08/canceriq-raises-4-8m-series-a-funding-round-for-cancer-precision-health-technology/

The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondent...

https://medcitynews.com/2020/08/most-hospital-health-systems-see-increase-in-genomics-genetics-vendors-by-2023-report-finds/

A Q&A with executives from Seven Bridges, a bioinformatics analysis business, highlights the company’s work in the precision medicine sector. The post Founders’ story: Seven Bridges ap...

https://medcitynews.com/2020/07/founders-story-seven-bridges/

Under the decision, Medicare patients with inherited cancer mutations such as BRCA will receive coverage for NGS testing. Drugs that treat BRCA-mutated breast and ovarian cancers include Astr...

https://medcitynews.com/2020/01/cms-to-cover-next-generation-sequencing-for-inherited-breast-ovarian-cancers/

Color vice president for research and scientific affairs Alicia Zhou explained that there is an ethical obligation to provide information on actionable genes, but costs and logistics have pre...

https://medcitynews.com/2019/10/verily-color-partner-on-delivering-genetic-information-for-project-baseline-participants/

To help cut down cancer disparities and deaths, OSF HealthCare recently announced that it will be expanding its genetic cancer risk assessment software into its Epic electronic health record ...

https://medcitynews.com/2019/09/inside-osf-healthcares-decision-to-incorporate-cancer-risk-assessment-software-in-its-ehr/

Salt Lake City-based Myriad Genetics’ GeneSight screening analyzes specific genes as a way to predict the effectiveness of 56 common medications for depression. The post UnitedHealthcare ...

https://medcitynews.com/2019/08/unitedhealthcare-starts-coverage-of-myriad-genetics-genomic-depression-test/

On the company’s LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to two shares. The post LunaPBC is trading company shares...

https://medcitynews.com/2019/07/lunapbc-is-trading-company-shares-for-member-health-data/

The company, which was founded in 2014 by a team including genetics pioneer Leroy Hood, raised more than $50 million over its existence from investors including Maveron, Polaris Partners and ...

https://medcitynews.com/2019/04/personalized-health-coaching-startup-arivale-shuts-down/

Helix is responsible for sequencing the user’s DNA and passing results to PerkinElmer, which will provide data analysis and interpretative services using the company’s team of medical ge...

https://medcitynews.com/2019/04/helix-and-perkinelmer-launch-geneprism-genetic-risk-product-in-competition-with-23andme/

Burke joined the Mountain View, California-based chronic disease management company late last year after spending more than two decades at EHR giant Cerner. The post Livongo CEO Zane Burke ...

https://medcitynews.com/2019/03/livongo-ceo-zane-burke-on-his-move-from-cerner-big-techs-intersection-with-healthcare/

These two announcements come after Deborah DiSanzo left her role as IBM Watson Health general manager last year. The post IBM Watson Health invests $50M in research collaborations, teams u...

https://medcitynews.com/2019/02/ibm-watson-health-collaborations-broad-institute/

The risks associated with ignoring genetic factors far exceed the complications of including them and going forward there will be more clinical trials having a genetic or precision medicine c...

https://medcitynews.com/2018/12/adding-genetics-to-the-clinical-trial-ecosystem/